1. Market Research
  2. > Biotechnology
  3. > Medical Biotechnology Market Trends
Tissue Engineering and Regeneration: Technologies and Global Markets

Tissue Engineering and Regeneration: Technologies and Global Markets

  • May 2019
  • 200 pages
  • ID: 5779655
  • Format: PDF
  • By BCC Research

Summary

Table of Contents

Report Scope:
This report covers all revenues earned by regeneration therapies.These therapies are extensively used to replace and regenerate the cells, genes and tissues in a patient’s body.

The report considers revenue generated by products and services in the regenerative medicine market.Services include tools, along with cell and gene bank charges, where the cells and tissues are stored and treated properly pre- and post-experimentation and treatment.

The report also covers revenues earned by small molecules and biologics (drugs) that speed up the regeneration process. Other drug therapy revenues (e.g., painkillers, analgesics) that can be used along with regenerative therapy are not included in the report, as they do not contribute to cell or tissue regeneration. The report covers all existing applications of regenerative medicine therapy.

The global tissue engineering and regeneration market is primarily categorized by segment, material, application and region.The major segments are therapeutic products, tools, banks and services.

Therapeutic products are further segmented into cell therapy, gene therapy, tissue engineering, and small molecules and biologics based on product type.Therapeutic products are also categorized into synthetic materials, biologically derived materials, genetically engineered materials, and small molecules and biologics based on material.

The report includes key technologies involved in regenerative medicine therapy.The study analyzes clinical trials and patents in different regions.

The report provides an in-depth analysis of key companies operating in the global tissue engineering and regeneration market.

By region, the market is segmented into North America, Europe, Asia-Pacific and ROW. Companies profiled in this report include Advanced Cell Technology, Arteriocyte, Athersys, Bioheart, BioMimetic Therapeutics, BioTissue Technologies, Cerapedics, Cook Biotech, CryoLife, Cytograft Tissue Engineering, Cytomedix, Cytori Therapeutics, Genzyme/Sanofi, Integra LifeSciences, International Stem Cell, LifeCell/Kinetic Concepts and Mesoblast.

Report Includes:
- 59 data tables and 56 additional tables
- An overview of the global market for tissue engineering and regeneration technologies within the industry
- Analysis of global market trends, with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
- A look at the future trends, products details, and therapies available in the field of tissue engineering
- Evaluation of the competitive environments, including new and potential markets for novel therapies and treatments
- Coverage of regulatory dynamics, pipeline analysis, patent analysis, and market drivers, restrains, and opportunities
- Comprehensive company profiles of leading market players, including Ocata Therapeutics, Inc. (Astellas Pharma, Inc.), Co.don AG, Cook Medical Inc., Cytori Therapeutics, Inc., and Kinetic Concepts, Inc. (KCI)

Summary
Advances in tissue engineering and regenerative medicine have increased the standard of living by restoring, maintaining and enhancing the functions of tissues and organs.The global tissue engineering and regeneration market was valued at REDACTED in 2017, and it is expected to grow at a compound annual growth rate (CAGR) of REDACTED from 2018 through 2023.

An increase in incidences of accidents, burn injuries and other trauma injuries have fueled the tissue engineering and regeneration market. According to Association for Safe International Road Travel (ASIRT) (U.S.), road traffic crashes are ranked as the ninth-leading cause of death and account for REDACTED of all deaths globally.
Approximately more than half of all road traffic deaths occur among young adults ages 15 to 44.The tissue-engineering market in trauma injuries is less prevalent due to high costs and lower success rates.

Tissue engineering is widely used in organ transplantation.

The growth of the tissue engineering and regeneration market is hampered due to stiff regulations, a lack of awareness and a low rate of adoption.Regulatory policies are countering market expansion.

Advancements in stem cell technologies have created a novel platform for regenerative medicines.There have been recent developments in the field of stem cells with the creation of human-induced pluripotent stem cells (iPSCs).

The combination of multiple innovative technologies led to the fundamental breakthrough in how scientists look at aberrant disease states.Recently, CRISPR has been used on the genome of iPSCs, resulting in significant changes in creating cell models of various diseases.

However, these advances have given rise to ethical issues. These ethical conflicts are putting pressure on governments to regulate the commercialization of tissue repair and regeneration. Furthermore, tissue damage and organ failure are increasing the number of health-related problems, thus accounting for more than half of all annual healthcare expenses in the U.S., Europe and the rest of the world.

The global tissue engineering and regeneration market is primarily segmented into components, applications and region.The component market is categorized into therapeutic products, tools, banks and services.

Therapeutic products are further segmented into cell therapy, gene therapy, tissue engineering, and small molecules and biologics based on product type.Therapeutic products are also categorized into synthetic materials, biologically derived materials, genetically engineered materials,and small molecules and biologics based on material.

Cell therapy technologies have a better adopt ion rate than others. Moreover, these technologies, especially those based on stem cell research, have the most
potential for the tissue engineering and regeneration market. The cell therapy segment of therapeutic products, which dominates the global regenerative medicine market, is valued at REDACTED in 2017, and it is expected to grow at a CAGR of REDACTED during the analysis period. Furthermore, the small molecule and biologic market is the fastest-growing segment, with a CAGR of REDACTED from 2018 through 2023.

In terms of materials, the global tissue engineering and regeneration market is dominated by biologically derived materials.These materials are widely commercialized for tissue engineering due to their high stability for results.

The biologically derived material market was valued at nearly REDACTED in 2017, and it is expected to grow at a CAGR of REDACTED during the forecast period.

The synthetic material market has the highest potential in the future. It is expected to be the fastest - growing market, with a CAGR of REDACTED during the forecast pe riod.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
10% Off

($5500)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Orthobiologics for Musculoskeletal Soft Tissue Replacement and Regeneration

Orthobiologics for Musculoskeletal Soft Tissue Replacement and Regeneration

  • $ 4750
  • October 2019

OverviewThis medical market and technology report provides a comprehensive discussion of the global market for orthobiologics for musculoskeletal soft tissue replacement and regeneration (including cell-based ...

Bone Grafts and Substitutes - Medical Devices Pipeline Assessment, 2019

Bone Grafts and Substitutes - Medical Devices Pipeline Assessment, 2019

  • $ 4000
  • October 2019

Bone Grafts and Substitutes - Medical Devices Pipeline Assessment, 2019SummaryMedical Devices sector report, “Bone Grafts and Substitutes - Medical Devices Pipeline Assessment, 2019" provides an overview ...

C-X-C Chemokine Receptor Type 2 - Pipeline Review, H2 2019

C-X-C Chemokine Receptor Type 2 - Pipeline Review, H2 2019

  • $ 3500
  • November 2019

C-X-C Chemokine Receptor Type 2 - Pipeline Review, H2 2019SummaryC-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 ...


ref:plp2019

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on